There are a number of potential vaccine candidates—approximately 133 globally, according to the World Health Organisation—that are in various stages of clinical trials; hence, there will not be one single country or company dominating vaccine production, unless companies like Astra Zeneca keep signing deals with governments for supply if their candidate proves successful.
